Adverse Drug Reactions
17
1
2
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
9%
1 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (17)
Ofloxacin Concentration-toxicity Relationship in the Elderly
Effect of Epstein-Barr Virus on Macrophage M2/M1 Migration and EphA2 Expression in Adverse Drug Reactions
Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events
Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.
Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study
Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy
The Knowledge, Attitudes and Practices of Healthcare Workers on Drug Hypersensitivity Reactions in Children
The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole
Pharmacogenetic Testing Among Home Health Patients
Clinical Trial of a New Software ENgine for the Assessment & Optimization of Drug and Non-drug Therapy in Older peRsons
Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study
Collection, Evaluation and Assessment of Adverse Drug Reactions on the Oncology Ward
Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years
YouScript IMPACT Registry
The Effect of Medication Review in High-risk Emergency Department Patients
Adverse Drug Event Prevention Using Structured Pharmacist Review
A Pharmacovigilance Study for AdimFlu-S (A/H1N1) Influenza Vaccine in Pregnant Women